Please assess the completion status of the following clinical trial:

Trial Title: Acute and Short-term Chronic Effects of Galvus (Vildagliptin) in Diabetes Type 2 Obese Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* All patients should have BMI \> 30kg/m²~* Present untreated diabetes mellitus type 2~* Age between 19 and 50 years~* Waist Circumference \> 80 cm~Exclusion Criteria:~* Renal, coronary vascular or peripheral, hematologic or hepatic disease~* Presence of severe hypertriglyceridemia (\> 400mg/dl)~* Smokers~* Significant body mass loss (\> 5%) within the six months prior to the study

- Gender: FEMALE
- Minimum Age: 19 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Metformin (Type: EXPERIMENTAL): Metformin 850mg/pill will be administered at lunch time and dinner time for 30 days
- Vildagliptina (Type: EXPERIMENTAL): Vildagliptin 50mg/pill will be administered at 10 AM and at 6 PM also for 30 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).